Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Nuclear factor 1 X-type (230-310 aa) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
NFIX |
Gene ID: |
4784 |
Uniprot ID: |
NFIX_HUMAN |
Immunogen Region: |
230-310 aa |
Specificity: |
NFIX Polyclonal Antibody detects endogenous levels of protein. |
Immunogen: |
Synthesized peptide derived from the human protein at the amino acid range 230-310 |
Function | Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. |
Protein Name | Nuclear Factor 1 X-TypeNf1-XNuclear Factor 1/XCcaat-Box-Binding Transcription FactorCtfNuclear Factor I/XNf-I/XNfi-XTggca-Binding Protein |
Database Links | Reactome: R-HSA-73980Reactome: R-HSA-749476 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Nuclear Factor 1 X-Type antibodyAnti-Nf1-X antibodyAnti-Nuclear Factor 1/X antibodyAnti-Ccaat-Box-Binding Transcription Factor antibodyAnti-Ctf antibodyAnti-Nuclear Factor I/X antibodyAnti-Nf-I/X antibodyAnti-Nfi-X antibodyAnti-Tggca-Binding Protein antibodyAnti-NFIX antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance